ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 032,99
-0,40%
Dow Jones
38 386,09
0,00%
DAX
18 000,05
-0,73%
Brent Oil
87,455
0,19%
Bitcoin
61 192,53
-4,14%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Atea Pharmaceuticals Inc (AVIR)

  7. Atea Pharmaceuticals Inc (AVIR) Actualités

AVIR Atea Pharmaceuticals Inc

3,71
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Atea Pharmaceuticals Inc AVIR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 3,71 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,71
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202413:00GLOBEAtea Announces Presentation of Data Highlighting Favorable..
27/3/202412:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
28/2/202422:18EDGAR2Form 8-K - Current report
28/2/202422:05GLOBEAtea Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202413:00GLOBEAtea Pharmaceuticals to Host Fourth Quarter and Full Year..
03/2/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
08/1/202422:05GLOBEAtea Pharmaceuticals Announces Positive Initial Data from..
03/1/202413:00GLOBEAtea Pharmaceuticals to Present at the 42nd Annual J.P...
13/11/202313:00GLOBEAtea Pharmaceuticals Presents Promising Bemnifosbuvir and..
08/11/202322:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:15EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202313:00GLOBEAtea Pharmaceuticals Announces Participation at Upcoming..
02/11/202312:00GLOBEAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir..
01/11/202312:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2023 Financial..
06/9/202313:00GLOBEAtea Pharmaceuticals to Present at the Morgan Stanley 21st..
08/8/202322:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:21EDGAR2Form 8-K - Current report
08/8/202322:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202313:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2023 Financial..
15/6/202313:00GLOBEAtea Pharmaceuticals Announces First Patient Dosed in Phase..
05/6/202322:20GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
30/5/202313:00GLOBEAtea Pharmaceuticals’ Board of Directors Unanimously Rejects..
23/5/202322:05GLOBEAtea Pharmaceuticals Confirms Receipt of Unsolicited..
08/5/202322:05GLOBEAtea Pharmaceuticals Reports First Quarter 2023 Financial..
01/5/202322:05GLOBEAtea Pharmaceuticals to Host First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
AVIR
Atea Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés